4D pharma | EFFECT: Others
Apr 29, 2022 00:15 ET
4D pharma | EFFECT: Others
Mar 31, 2022 00:15 ET
4D pharma | 424B3: Prospectus
Feb 18, 2022 17:02 ET
4D pharma | 424B3: Prospectus
Feb 18, 2022 17:01 ET
4D pharma | 424B3: Prospectus
Jan 10, 2022 15:34 ET
4D pharma | 424B3: Prospectus
Jan 10, 2022 15:31 ET
4D pharma | EFFECT: Others
Oct 15, 2021 00:15 ET
4D pharma | 424B3: Prospectus
Oct 14, 2021 16:51 ET
4D pharma | EFFECT: Others
Oct 4, 2021 00:15 ET
4D pharma | 424B3: Prospectus
Sep 30, 2021 21:55 ET
4D pharma | 424B3: Prospectus
Aug 11, 2021 15:17 ET
4D pharma | 424B3: Prospectus
Jul 27, 2021 16:32 ET
4D pharma | 424B3: Prospectus
May 25, 2021 09:00 ET
4D pharma | EFFECT: Others
May 25, 2021 00:18 ET
4D pharma | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Mar 18, 2021 14:07 ET
4D pharma | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Mar 17, 2021 16:42 ET
4D pharma | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Mar 17, 2021 08:59 ET
4D pharma | 424B3: Prospectus
Mar 8, 2021 16:05 ET
4D pharma | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Mar 1, 2021 06:04 ET
4D pharma | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Mar 1, 2021 06:03 ET
No Data
No Data